Chondroitin sulfate degradation bolsters Proteus mirabilis growth and colonization of the catheterized urinary tract

Read full text
Authors: Benjamin C. Hunt, Vitus Brix, Namrata Deka, Brian S. Learman, Aimee L. Brauer, Braden M. Shipman, Nicole J. De Nisco, Chelsie E. Armbruster
Cited by: 0
References: 66

Abstract

ABSTRACT Glycosaminoglycans (GAGs) are negatively charged polysaccharides composed of repeating disaccharide units and are essential components of the extracellular matrix throughout numerous tissues. The bladder urothelium has a protective GAG layer that primarily consists of chondroitin sulfate (CS), heparan sulfate (HS), and hyaluronic acid (HA), and urinary tract pathogens must either degrade or otherwise circumvent this layer to infect the urothelium. In this study, we investigated GAG degradation by Proteus mirabilis, a common and persistent colonizer of the catheterized urinary tract. Almost all P. mirabilis urinary tract isolates harbor a putative chondroitin endolyase (PMI2127), exolyase (PMI2128), and sulfatase (PMI2124). By generating mutant and complemented strains of these genes, we determined that P. mirabilis strain HI4320 degrades multiple forms of CS under numerous culture conditions, including during growth in human urine, and can use CS degradation products as a carbon source. Sulfatase and endolyase activities were required for efficient degradation of all CS types, while the exolyase only contributed to using CS-B or CS-C as a carbon source. Interestingly, only endolyase activity contributed to colonization in a murine model of catheter-associated urinary tract infection (CAUTI), although the colonization defect was even more pronounced when both the endolyase and exolyase were disrupted. The colonization defect was specific to the CAUTI model, likely due to the impact of catheterization on the GAG landscape of the bladder. Limiting CS degradation by P. mirabilis may therefore reduce the risk of ascending infection in catheterized patients.

Fields of Study & Subjects

Urinary Tract Infections Management Proteoglycans and glycosaminoglycans research Escherichia coli research studies

Publication details

Journal / source
Infection and Immunity
Volume
94
Issue
10
Pages
e0022326–e0022326
Publication date
2 September 2026
Language
EN